Tag : pharmaceutical

CCT Impact

MediPharm Labs Enters United States Pharmaceutical Market with Submission of FDA DMF

CCT IMPACT Agent
by CCT IMPACT Agent098
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has completed a US FDA DMF for pure natural CBD API. The DMF will enable MediPharm to supply approved API to pharmaceutical companies currently conducting late-stage......
CCT Impact

The Cannabinoid Derived Pharmaceutical Market worth US$ 11.2 Billion by 2030 – Exclusive Report by InsightAce Analytic

CCT IMPACT Agent
by CCT IMPACT Agent091
The newly published report titled “Global Cannabinoid Derived Pharmaceutical Market – By Trends, Industry Competition Analysis, Pipeline Analysis, COVID-19 Analysis, Revenue (US$ Millions) and Forecast Till 2030.” features detailed industry analysis and an extensive clinical trial/pipeline study on the market, exploring its significant factors. According to the latest pharmaceutical market......
CCT Impact

Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company

CCT IMPACT Agent
by CCT IMPACT Agent0308
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany. The C³ business develops and manufactures pharmaceutical......
CCT Impact

Tikun Olam-Cannbit takes another step into the pharmaceutical arena

CCT IMPACT Agent
by CCT IMPACT Agent0182
Tikun Olam Cannbit (TASE: TKUN) reports acquisition of 20% of the leading Femtech company Gynica, developer of cannabinoid-based solutions for women’s health. Tikun Olam-Cannbit today reported an estimated NIS 5 million agreement for investment in 20% of the shares in  Gynica, the leader in initial patented development in gynecology that has been clinically proven, in exchange......
CCT Impact

PAOG To Publish Latest CBD Pharmaceutical Developments Tomorrow, Tuesday April 13, 2021

CCT IMPACT Agent
by CCT IMPACT Agent0202
PAO Group, Inc. (USOTC: PAOG) today confirmed a management update on the company’s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive......
CCT Impact

PAOG U.S. Patent Backed CBD Pharmaceutical Development Remains On Track

CCT IMPACT Agent
by CCT IMPACT Agent0199
PAO Group, Inc. (USOTC: PAOG) today announced a management update on the company’s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive......
Market Watch

Ikänik Farms Becomes First to Export Pharmaceutical Grade Cannabis to Mexico for COVID-19 Research

CCT IMPACT Agent
by CCT IMPACT Agent0358
Ikänik Farms, Inc. (the “Company” or “Ikänik”) is pleased to announce that  Pideka SAS (“Pideka”), a wholly owned Colombian subsidiary of the Company, has signed a collaborative agreement with CAS Biotechnology, for cannabis research on the potential medical benefits in the treatment of COVID-19, with pharmaceutical grade cannabis oil provided......
Market Watch

Ikänik Farms Becomes the First to Complete Commercial Sale of Full Spectrum Pharmaceutical Cannabis Oil in Colombia

CCT IMPACT Agent
by CCT IMPACT Agent0331
Ikänik Farms Inc. (the “Company”) is pleased to announce its wholly owned, Colombian subsidiary Pideka SAS (“Pideka”), has successfully completed its initial commercial and R&D sales of full spectrum Cannabis oil, for use in Formula Magistral, Colombia’s approved pharmaceutical method. “We are pleased to be the first in Colombia to complete the sale of pharmaceutical grade,......
CCT Impact

Nextleaf Solutions Prepares for Potential Pharmaceutical Participation with Prodrug Patent

CCT IMPACT Agent
by CCT IMPACT Agent0362
Nextleaf Solutions Ltd. (“Nextleaf“, “OILS“, or the “Company“) (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA), Canada’s most innovative cannabis extractor, announced today that the United States Patent and Trademark Office has granted the Company a patent for the acetylation of cannabinoids. More specifically, the patent describes a process for acetylating delta 9-tetrahydrocannabinol (“THC”), and......
CCT Impact

In 2020, Cannabis Construction Must Offer Security of a Bank, Compliance of a Pharmaceutical Company, Aesthetic of a High-end Retailer

CCT IMPACT Agent
by CCT IMPACT Agent0486
Legal recreational cannabis is a new industry in Illinois—and it’s in dire need of customized facilities. The first month of recreational cannabis sales in Illinois amounted to nearly $40 million. Sales figures spell opportunity both for cannabis companies and for experts in building special-purpose facilities for the industry’s stringent regulations and experience-driven customers. Andy......